news
Representatives of the Podolsk administration visit the Petrovax Pharm manufacturing complex
During the visit, they discussed with the plant’s management the company’s 2025 results and achievements, prospects for further development in innovative R&D, and opportunities for new investment projects
Innovative immunotherapy for lung cancer authorized in Russia
How the dietary supplements market is changing in Russia: the need to shift toward medical standards
Investment project by Petrovax Pharm for market launch of Areima® wins industry award
A breakthrough in the treatment of bacterial vaginosis: adjuvant treatment reduces the risk of recurrence
Immune overload: what leads to a prolonged course of acute respiratory viral infections
Petrovax named “Company of the Year” in the dietary supplements category at MedMen Awards 2025
Petrovax Pharm confirms compliance with EU GMP standards
A hidden epidemic: Russia revises its approach to combating iron deficiency
